Targeted oncology tools Intio specializes in interventional oncology planning, imaging guidance, and quantitative analysis. This presents a sales opportunity to offer advanced software modules, integrations, or add-ons that enhance tumor treatment planning and outcome assessment for radiology and interventional teams.

FDA cleared asset The ClearStart SVM Segmentation and Volumetric Measurement system has FDA 510(k) clearance for lung, liver, and lymph node lesions. A sales angle is expanding adoption in additional organ sites, clinical workflows, or ancillary modules that leverage the validated segmentation capabilities.

Small team agility With a lean employee base, Intio may prioritize scalable, low-overhead deployments, cloud-based or SaaS solutions, and rapid ROI demonstrations. Offer streamlined implementation, training packages, and concierge support to accelerate adoption.

Revenue scale Current revenue range and modest funding indicate a growth-focused customer segment receptive to value-based pricing, bundled licenses, and performance-driven contracts tied to improved treatment planning efficiency and decision support.

Tech stack fit Core technologies include MySQL, PHP, Ubuntu, and web-based tools. Propose integration partnerships with existing hospital information systems or PACS, API-based data exchange, and secure, compliant deployment options to fit their architecture.